Compare ONC & EQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ONC | EQT |
|---|---|---|
| Founded | 2010 | 1925 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.8B | 34.2B |
| IPO Year | N/A | N/A |
| Metric | ONC | EQT |
|---|---|---|
| Price | $353.92 | $56.79 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 20 |
| Target Price | ★ $370.25 | $65.00 |
| AVG Volume (30 Days) | 293.5K | ★ 11.7M |
| Earning Date | 02-26-2026 | 02-17-2026 |
| Dividend Yield | N/A | ★ 1.16% |
| EPS Growth | N/A | ★ 334.04 |
| EPS | 0.58 | ★ 2.91 |
| Revenue | $4,972,687,000.00 | ★ $7,708,868,000.00 |
| Revenue This Year | $895.40 | $67.04 |
| Revenue Next Year | $22.04 | $11.10 |
| P/E Ratio | $571.32 | ★ $19.54 |
| Revenue Growth | 50.43 | ★ 66.75 |
| 52 Week Low | $196.45 | $43.57 |
| 52 Week High | $385.22 | $62.23 |
| Indicator | ONC | EQT |
|---|---|---|
| Relative Strength Index (RSI) | 55.15 | 53.27 |
| Support Level | $328.91 | $54.01 |
| Resistance Level | $355.43 | $56.56 |
| Average True Range (ATR) | 9.27 | 1.75 |
| MACD | 0.07 | 0.21 |
| Stochastic Oscillator | 65.61 | 63.49 |
Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeOne is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeOne runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeOne's revenue.
EQT is an independent natural gas production company. It focuses its operations in the cores of the Marcellus and Utica shales, located in the Appalachian Basin in the Eastern United States. Its main customers include marketers, utilities, and industrial operators in the Appalachian Basin. The company has three reportable segments in production, gathering, and its transmission segment, which is now an operated joint venture with Blackstone. All the firm's operating revenue is generated in the US, with most revenue flowing from the Marcellus Shale field and through the sale of natural gas.